BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24183310)

  • 1. Characterisation of Aicardi-Goutières syndrome.
    Krägeloh-Mann I
    Lancet Neurol; 2013 Dec; 12(12):1131-2. PubMed ID: 24183310
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.
    Rice GI; Forte GM; Szynkiewicz M; Chase DS; Aeby A; Abdel-Hamid MS; Ackroyd S; Allcock R; Bailey KM; Balottin U; Barnerias C; Bernard G; Bodemer C; Botella MP; Cereda C; Chandler KE; Dabydeen L; Dale RC; De Laet C; De Goede CG; Del Toro M; Effat L; Enamorado NN; Fazzi E; Gener B; Haldre M; Lin JP; Livingston JH; Lourenco CM; Marques W; Oades P; Peterson P; Rasmussen M; Roubertie A; Schmidt JL; Shalev SA; Simon R; Spiegel R; Swoboda KJ; Temtamy SA; Vassallo G; Vilain CN; Vogt J; Wermenbol V; Whitehouse WP; Soler D; Olivieri I; Orcesi S; Aglan MS; Zaki MS; Abdel-Salam GM; Vanderver A; Kisand K; Rozenberg F; Lebon P; Crow YJ
    Lancet Neurol; 2013 Dec; 12(12):1159-69. PubMed ID: 24183309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.
    Crow YJ; Chase DS; Lowenstein Schmidt J; Szynkiewicz M; Forte GM; Gornall HL; Oojageer A; Anderson B; Pizzino A; Helman G; Abdel-Hamid MS; Abdel-Salam GM; Ackroyd S; Aeby A; Agosta G; Albin C; Allon-Shalev S; Arellano M; Ariaudo G; Aswani V; Babul-Hirji R; Baildam EM; Bahi-Buisson N; Bailey KM; Barnerias C; Barth M; Battini R; Beresford MW; Bernard G; Bianchi M; Billette de Villemeur T; Blair EM; Bloom M; Burlina AB; Carpanelli ML; Carvalho DR; Castro-Gago M; Cavallini A; Cereda C; Chandler KE; Chitayat DA; Collins AE; Sierra Corcoles C; Cordeiro NJ; Crichiutti G; Dabydeen L; Dale RC; D'Arrigo S; De Goede CG; De Laet C; De Waele LM; Denzler I; Desguerre I; Devriendt K; Di Rocco M; Fahey MC; Fazzi E; Ferrie CD; Figueiredo A; Gener B; Goizet C; Gowrinathan NR; Gowrishankar K; Hanrahan D; Isidor B; Kara B; Khan N; King MD; Kirk EP; Kumar R; Lagae L; Landrieu P; Lauffer H; Laugel V; La Piana R; Lim MJ; Lin JP; Linnankivi T; Mackay MT; Marom DR; Marques Lourenço C; McKee SA; Moroni I; Morton JE; Moutard ML; Murray K; Nabbout R; Nampoothiri S; Nunez-Enamorado N; Oades PJ; Olivieri I; Ostergaard JR; Pérez-Dueñas B; Prendiville JS; Ramesh V; Rasmussen M; Régal L; Ricci F; Rio M; Rodriguez D; Roubertie A; Salvatici E; Segers KA; Sinha GP; Soler D; Spiegel R; Stödberg TI; Straussberg R; Swoboda KJ; Suri M; Tacke U; Tan TY; te Water Naude J; Wee Teik K; Thomas MM; Till M; Tonduti D; Valente EM; Van Coster RN; van der Knaap MS; Vassallo G; Vijzelaar R; Vogt J; Wallace GB; Wassmer E; Webb HJ; Whitehouse WP; Whitney RN; Zaki MS; Zuberi SM; Livingston JH; Rozenberg F; Lebon P; Vanderver A; Orcesi S; Rice GI
    Am J Med Genet A; 2015 Feb; 167A(2):296-312. PubMed ID: 25604658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
    Livingston JH; Crow YJ
    Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release.
    Cuadrado E; Michailidou I; van Bodegraven EJ; Jansen MH; Sluijs JA; Geerts D; Couraud PO; De Filippis L; Vescovi AL; Kuijpers TW; Hol EM
    J Immunol; 2015 Apr; 194(8):3623-33. PubMed ID: 25769924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of genotype-phenotype variability in siblings with Aicardi Goutières Syndrome (AGS).
    de Barcelos IP; Woidill S; Gavazzi F; Modesti NB; Sevagamoorthy A; Vanderver A; Adang L
    Mol Genet Metab; 2024 May; 142(1):108346. PubMed ID: 38368708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.
    Ramantani G; Kohlhase J; Hertzberg C; Innes AM; Engel K; Hunger S; Borozdin W; Mah JK; Ungerath K; Walkenhorst H; Richardt HH; Buckard J; Bevot A; Siegel C; von Stülpnagel C; Ikonomidou C; Thomas K; Proud V; Niemann F; Wieczorek D; Häusler M; Niggemann P; Baltaci V; Conrad K; Lebon P; Lee-Kirsch MA
    Arthritis Rheum; 2010 May; 62(5):1469-77. PubMed ID: 20131292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
    Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
    Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in Aicardi-Goutieres syndrome.
    Izzotti A; Longobardi M; Cartiglia C; Anzuini F; Arrigo P; Fazzi E; Orcesi S; Piana RL; Pulliero A
    J Child Neurol; 2012 Jan; 27(1):51-60. PubMed ID: 21862834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.
    Goncalves A; Karayel E; Rice GI; Bennett KL; Crow YJ; Superti-Furga G; Bürckstümmer T
    Hum Mutat; 2012 Jul; 33(7):1116-22. PubMed ID: 22461318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations.
    du Moulin M; Nürnberg P; Crow YJ; Rutsch F
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):E232; author reply E233. PubMed ID: 21633013
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical Aicardi-Goutieres syndrome: is the WRN locus a modifier?
    Lessel D; Saha B; Hisama F; Kaymakamzade B; Nurlu G; Gursoy-Özdemir Y; Thiele H; Nürnberg P; Martin GM; Kubisch C; Oshima J
    Am J Med Genet A; 2014 Oct; 164A(10):2510-3. PubMed ID: 24989684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-stranded nucleic acids promote SAMHD1 complex formation.
    Tüngler V; Staroske W; Kind B; Dobrick M; Kretschmer S; Schmidt F; Krug C; Lorenz M; Chara O; Schwille P; Lee-Kirsch MA
    J Mol Med (Berl); 2013 Jun; 91(6):759-70. PubMed ID: 23371319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and neuroradiologic variability of Aicardi-Goutiéres syndrome: Two siblings with RNASEH2C mutation and a boy with TREX1 mutation.
    Uyur Yalçın E; Maraş Genç H; Kara B
    Turk J Pediatr; 2015; 57(5):504-8. PubMed ID: 27411419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aicardi-Goutières syndrome (AGS).
    Stephenson JB
    Eur J Paediatr Neurol; 2008 Sep; 12(5):355-8. PubMed ID: 18343173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMHD1 prevents autoimmunity by maintaining genome stability.
    Kretschmer S; Wolf C; König N; Staroske W; Guck J; Häusler M; Luksch H; Nguyen LA; Kim B; Alexopoulou D; Dahl A; Rapp A; Cardoso MC; Shevchenko A; Lee-Kirsch MA
    Ann Rheum Dis; 2015 Mar; 74(3):e17. PubMed ID: 24445253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SAMHD1 knockout mouse model: in vivo veritas?
    Roesch F; Schwartz O
    EMBO J; 2013 Sep; 32(18):2427-9. PubMed ID: 23963314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.
    Berger A; Sommer AF; Zwarg J; Hamdorf M; Welzel K; Esly N; Panitz S; Reuter A; Ramos I; Jatiani A; Mulder LC; Fernandez-Sesma A; Rutsch F; Simon V; König R; Flory E
    PLoS Pathog; 2011 Dec; 7(12):e1002425. PubMed ID: 22174685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
    Fisher AJ; Beal PA
    RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
    Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
    Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.